NEW YORK ( TheStreet) -- Accuray (Nasdaq: ARAY) hit a new 52-week low Thursday as it is currently trading at $4.75, below its previous 52-week low of $4.76 with 721,364 shares traded as of 1:41 p.m. ET. Average volume has been 774,900 shares over the past 30 days.

Accuray has a market cap of $315.2 million and is part of the health care sector and health services industry. Shares are down 23.4% year to date as of the close of trading on Wednesday.

Accuray Incorporated designs, develops, and sells the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The company has a P/E ratio of 87.3, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your ARAY trading strategies and win cash in our stock game.

TheStreet Ratings rates Accuray as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and weak operating cash flow. You can view the full Accuray Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.